The American College of Radiology® (ACR®) is a founding supporter of the Lancet Oncology Commission on Medical Imaging and Nuclear Medicine, which issued a groundbreaking report today at the European Congress of Radiology 2021 annual meeting.
ACR member Hedvig Hricak, MD, PhD, FACR, is Lead Commissioner. Former ACR Board of Chancellors Chairs James A. Brink, MD, FACR, and Geraldine B. McGinty, MD, FACR, also serve on the international commission.
The report, published March 4 in the Lancet, stated, “We propose actions and investments that would enhance access to imaging equipment, workforce capacity, digital technology, radiopharmaceuticals, and research and training programmes in LMICs [low-income and middle-income countries], to produce massive health and economic benefits and reduce the burden of cancer globally.” The ACR has long supported such goals.
“The ACR invested in the formation of this effort and strongly supports the goals that the commission has laid out. We are proud that ACR members continue to take a leading role in increasing access to lifesaving radiology services worldwide,” said William T. Thorwarth, MD, FACR, ACR Chief Executive Officer.
ACR support for the new Lancet commission is in keeping with the ACR Foundation International Outreach Program and the ACR Foundation Global Humanitarian Award, which logistically and financially support efforts to improve and increase access to quality radiological services in low-income and middle-income countries.
To speak with an ACR spokesperson, media can contact Shawn Farley or Debbie Kakol at email@example.com or call 703-648-8936.